INTRODUCTION
Healing, a dynamic and multifactorial process divided into three phases – inflammatory,
proliferative, and remodeling – is one of the most important defense mechanisms of
the human body by preventing blood loss and ensuring tissue repair. However, as it
is a dynamic process, several known and unknown factors can positively affect it,
resulting in an adequate recovery of the injured tissue.
Thus, when the site is the skin, the aim is to return to the state as close as possible
to the previous one, which, depending on the mechanism and type of trauma, is not
achieved1. Despite all the efforts of the cellular recovery mechanism, many cases do not reach
the desired aesthetic or functional appearance2.
From the classification of scars, it was possible to elaborate protocols for their
treatment, which differ in light or more invasive therapies, depending on the severity
of the case. Thus, because they are considered more severe, scars classified as keloids
require different therapeutic strategies3, 4.
Keloids, first described and named by Alibert in 18065, were presented as a growth similar to the projection of branches or the claws of
a crab, which from the Greek khele derived the English word keloid, being translated into Portuguese as queloide.
Considered a benign tumor, it is characterized by the expansion of the limits of the
initial lesion with a prolonged course of activity, in addition to having a unique
pathophysiology and multiple specific genetic and cellular factors, with many of its
variables not yet fully understood6. At the histological level, there is a chronic inflammation of the reticular dermis,
with increased fibroblasts and collagen, specifically type I, eosinophilic and hyalinized.
So far, it is known that there is a greater development and growth of keloids during
puberty, in addition to an increase during pregnancy and a decrease after menopause7. Among the factors that promote its emergence, we can highlight genetics, the site
of the initial lesion, and ethnicity8.
Although not yet fully elucidated, several findings suggest genetic influence as a
predisposing factor to the formation of keloids. For example, some families have multiple
members affected, and the prevalence in twins is more frequent. When evaluating such
families, possible patterns of autosomal dominant heterogeneity are observed, but
cases suggesting recessive or X6-linked inheritance have also been described.
In addition to being associated with the genetic component, ethnicity has special
emphasis when evaluated along with the phototypes of patients according to the Fitzpatrick
scale9. As it is more frequent in blacks, Hispanics, and Asians, a possible relationship
with the activity of melanocytes during the healing process can be traced.
Furthermore, the location of the keloid can directly affect its recurrence rate. Based
on the current literature, systematic reviews and meta-analyses have shown high recurrence
rates in the trunk region, up to three times higher than in the head and neck region,
including ears, or even when compared to the limbs. Therefore, it is believed that
the variation of skin tension forces in different body regions possibly generates
these statistically significant differences10.
Despite its non-lethality, keloids impair mental and emotional quality of life, as
demonstrated in recent studies, which is recovered after treatment11.
For its treatment, it is important to point out that exclusive excision, without association
with an adjuvant method, has high recurrence rates, close to 50%, with an increase
with each new attempt, especially in the first four years12.
Several studies have been trying to demonstrate the great importance of combining
therapies, but still without a definitive result for this problem. New technologies
are being associated with classic treatments, but also without showing maximum effectiveness13, 14.
Among the classic treatments, we can highlight the intralesional infiltration of drugs,
such as corticosteroids and 5-fluoracil, in addition to the various adjuvant radiotherapy
(RT) modalities: conventional RT, RT with an electron beam, RT in a single dose, and
conventional X-ray15, 16.
Radiotherapy interferes with the formation of keloids by inhibiting the release of
histamine by mast cells, reducing the proliferation of fibroblasts, and inhibiting
TGF-Beta1, which suppresses collagen production17. External radiotherapy after surgical excision of keloids, proposed in the 1960s18, showed that alone it could alleviate the symptoms but failed to resolve the lesion
when not associated with surgical excision. Furthermore, delay in performing radiotherapy
after excision has been shown to result in higher recurrence rates.
However, radiotherapy with adjuvant in treating keloids raises great concern due to
its carcinogenic potential. In 2009, a literature review found 5 cases that reported
this occurrence. However, it was impossible to define whether adequate doses had been
used in the reported cases and whether there was effective protection around the adjacent
tissues19. Therefore, the conclusion is that the risk of carcinogenesis does not prevent the
procedure from being performed, as long as care measures are taken for the surrounding
tissues, which includes protection of the thyroid and mammary glands, especially in
children and adolescents19.
Later, the possibility of treatment with internal or interstitial radiotherapy, known
as brachytherapy, was introduced20. In this modality, there is a great capacity to focus the radiation on the target
area, requiring a smaller dose and being more efficient, with less local radionecrosis
and adverse effects on healthy tissues close to the keloid. However, there is still
a higher hospital cost due to prolonged hospitalization and the use of specific and
poorly available materials19.
A work carried out in Brazil highlighted the importance of RT with an electron beam;
therefore, this possibility of treatment is maintained in the current approach routine
for these lesions in our institution21, 22.
The keloid scar remains a medical challenge, both because of the difficult definition
of the physiological factors that influence its formation and because of the need
to associate therapies that, in some cases, do not cure or prevent the appearance
of new lesions and recurrences.
OBJECTIVE
Therefore, this study aims to present a retrospective analysis of patients undergoing
postoperative radiotherapy at the Hospital das Clínicas da Faculdade de Medicina de
Botucatu over a four-year period to outline their epidemiological profile.
METHOD
Postoperative radiotherapy treatment protocol
Patients are referred to the Radiotherapy sector for clinical evaluation and scheduling
the first photoelectron radiotherapy session using the Clinac 2100-C linear accelerator
device (Varian-USA), with an energy of 4 million electron volts (Mev). 32Gray schemes
divided into 16 sessions are programmed, 5 days a week. At the end of the 16 sessions,
patients are reassessed for the need for booster doses of 8Gray in 4 sessions.
Radiotherapy was indicated for all referred patients who had undergone some previous
therapy without success for treating keloids or recurrences and who were going to
undergo keloid resection surgery.
The first session is always scheduled within 24 to 48 hours after keloid resection
surgery in adults and children.
Analysis of medical records
Retrospective analysis of medical records to assess the profile of patients who underwent
postoperative radiotherapy for the treatment of keloids at Hospital das Clínicas da
Faculdade de Medicina de Botucatu (HC-FMB) from January 2015 to January 2019, whose
data from the medical record allowed the inclusion in the study.
All female and male patients, adults, and children who underwent the treatment protocol
of the Radiotherapy service at HC-FMB UNESP were included.
Patients whose medical records did not have confirmatory data on keloid scar treatment
with surgery performed at the same hospital or an outpatient service and radiotherapy
were excluded.
As it is a cross-sectional study, it was possible to apply the STROBE initiative partially
(Strengthening the Reporting of Observational Studies in Epidemiology)23 to guide the review.
Researched variables - Epidemiological data
While analyzing medical records, we sought to determine the following variables: age,
sex, education level, city of origin, race, cause of the scar, previous treatments,
keloid site, treatment time, dose, and number of applications of radiotherapy.
Data collect
The data collection methodology used a form developed especially for this study (Appendix
I), filled out by the researcher in the Department of Plastic Surgery, while evaluating
the medical records of the patients included in the study. Data collection was carried
out after approval by the Research Ethics Committee.
Analysis of data from medical records
These data were tabulated using Microsoft Excel® software to perform descriptive statistical
analysis.
For qualitative variables, Pearson’s non-parametric chi-square test was performed,
while, for the quantitative variables, analysis of variance was used to compare the
different means and standard deviations related to the year of attendance and Student’s
t-test to compare the means and standard deviations according to the patient’s gender.
The Kaplan-Meier estimator was also used to study the duration of treatment and its
conclusion according to several variables (gender, specialty that made the referral
for radiotherapy, city of origin, education, previous treatments, race, keloid etiology,
and location).
The software used for statistical analysis was SAS version 9.2. The confidence interval
was 95%, considering the p-value statistically significant when less than 0.05.
CEP evaluation
The work complies with the recommendations of the Research Ethics Committee (CEP)
of the HC-FMB UNESP, being approved under opinion number 4,399,507.
RESULTS
After reviewing medical records, we identified 27 people treated in 2015, 43 in 2016,
21 in 2017, and 40 in 2018, totaling 131 patients. Some had more than one irradiated
lesion, with a total of 269 treated keloid scars.
Treatment duration ranged from 1 to 92 days after the first irradiation, averaging
51 days. The number of sessions was between 1 and 25, with a mean of 17. Table 1 shows the mean and standard deviation for the variables age, dose, number of applications,
and treatment time in days according to the years evaluated, being that in 2018 and
2017, there were a greater number of sessions than in previous years.
Table 1 - Mean, and standard deviation refer to age, dose, number of applications, and treatment
time according to years.
|
Year |
P |
2015 |
2016 |
2017 |
2018 |
Age (in years) |
31.5 |
29.2 |
33.5 |
31.9 |
0.17 |
12.9 |
10.7 |
11.8 |
10.9 |
Doses |
3164.0 |
3394.7 |
3668.2 |
3994.8 |
<0.001 |
991.1 |
834.6 |
835.4 |
574.0 |
Number of applications |
15.7 |
17.0 |
18.5 |
19.9 |
<0.001 |
5.0 |
4.2 |
4.3 |
2.9 |
Time (in days) |
36.1 |
37.4 |
46.1 |
56.2 |
<0.001 |
19.6 |
17.7 |
16.2 |
17.7 |
Table 1 - Mean, and standard deviation refer to age, dose, number of applications, and treatment
time according to years.
The majority of patients were white (78.8%), followed by black (10%), brown (3.7%),
and yellow (1.1%). There was no distinction of race described in the medical records
in 6.3% of the cases, in addition to not being possible to classify the patients according
to the Fitzpatrick scale (Table 2).
Table 2 - Frequency distribution of patients according to race and year.
Year |
Race |
Total |
Yellow |
White |
Brown |
Black |
N/D |
2015 |
- |
37 |
6 |
two |
5 |
50 |
0.0 |
74% |
12% |
4% |
10% |
100 (%) |
2016 |
- |
70 |
- |
6 |
- |
76 |
0.0 |
92.1% |
0.0 |
7.9% |
0.0 |
100 (%) |
2017 |
- |
39 |
3 |
15 |
9 |
66 |
0.0 |
59.1% |
4.6% |
22.7% |
13.6% |
100 (%) |
2018 |
3 |
66 |
1 |
4 |
3 |
77 |
3.9% |
85.7% |
1.3% |
5.2% |
3.9% |
100 (%) |
Total |
3 |
212 |
10 |
27 |
17 |
269 |
1.1% |
78.8% |
3.7% |
10% |
6.3% |
100 (%) |
Table 2 - Frequency distribution of patients according to race and year.
According to the Kaplan-Meier estimator, there was no difference between races in
terms of whether or not they completed treatment with radiotherapy (Figure 1).
Figure 1 - Kaplan-Meier estimator for total treatment time according to race and whether or not
treatment was completed (p=0.66).
Figure 1 - Kaplan-Meier estimator for total treatment time according to race and whether or not
treatment was completed (p=0.66).
As causes of keloid formation, a surgical incision was described in 49% of the lesions,
followed by earrings in 11%. There was no adequate information about the etiology
of the lesion in 30% of the cases. Other causes with an incidence of less than 2%
were, in descending order: trauma (blunt-cut injuries), acne, tumors, spontaneous
appearance, bites, and folliculitis (Table 3). According to the Kaplan-Meier estimator (Figure 2), those patients with keloid scars secondary to acne or of undetermined cause tended
to complete the treatment more than those caused by earrings and surgical incisions
(p<0.0001).
Table 3 - Distribution of patient frequencies according to cause and year.
Cause |
Year |
Total |
2015 |
2016 |
2017 |
2018 |
Acne |
- |
1 |
2 |
2 |
5 |
0.0 |
1.3% |
3% |
2.6% |
1.9% |
Earring |
18 |
14 |
- |
- |
32 |
36% |
18.4% |
0.0 |
0.0 |
11.9% |
Spontaneous |
- |
- |
- |
1 |
1 |
0.0 |
0.0 |
0.0 |
1.3% |
0.4% |
CBW |
2 |
4 |
- |
1 |
7 |
4.0% |
5.3% |
0.0 |
1.3% |
2.6% |
Folliculitis |
0 |
1 |
1 |
- |
2 |
0.0 |
1.3% |
1.5% |
0.0 |
0.7% |
Incision |
19 |
37 |
34 |
42 |
132 |
38% |
48.7% |
51.5% |
54.5% |
49.1% |
Bite |
2 |
- |
- |
- |
2 |
4% |
0.0 |
0.0 |
0.0 |
0.7% |
Burn |
1 |
2 |
- |
- |
3 |
2% |
2.6% |
0.0 |
0.0 |
1.1% |
N/D |
6 |
17 |
27 |
31 |
81 |
12% |
22.4% |
40.9% |
40.3% |
30.1% |
Tumor |
1 |
- |
2 |
- |
3 |
2% |
0.0 |
3% |
0.0 |
1.1% |
Wart |
1 |
- |
- |
- |
1 |
2% |
0.0 |
0.0 |
0.0 |
0.4% |
Total |
50 |
76 |
66 |
77 |
269 |
Table 3 - Distribution of patient frequencies according to cause and year.
Figure 2 - Kaplan-Meier estimator for total treatment time by cause and whether or not treatment
was completed (p<0.0001).
Figure 2 - Kaplan-Meier estimator for total treatment time by cause and whether or not treatment
was completed (p<0.0001).
Several locations were identified, the most prevalent being the ears – including the
lobe (33%), breasts (23%), and abdomen (22%). The other locations described were,
in descending order: thorax, neck, inguinal region, sternum, arm, armpit, hand, thigh,
leg, and lip (Table 4). Using the Kaplan-Meier estimator (Figure 3), we observed a greater chance of completing the treatment for those with injuries
to the neck, back, and chest (including sternum) than those with injuries to the abdomen
and earlobe (p<0.0001).
Table 4 - Frequency distribution of patients according to location and year.
Location |
Year |
Total |
2015 |
2016 |
2017 |
2018 |
Abdomen |
11 |
14 |
21 |
15 |
61 |
22% |
18.4% |
31.8% |
19.5% |
22.7% |
Armpit |
- |
- |
- |
2 |
2 |
0.0 |
0.0 |
0.0 |
2.6% |
0.7% |
Hip |
- |
- |
- |
2 |
2 |
0.0 |
0.0 |
0.0 |
2.6% |
0.7% |
Arm |
- |
5 |
- |
1 |
6 |
0.0 |
6.6% |
0.0 |
1.3% |
2.2% |
Thigh |
1 |
- |
- |
- |
1 |
2% |
0.0 |
0.0 |
0.0 |
0.4% |
Back |
1 |
- |
2 |
2 |
5 |
2% |
0.0 |
3% |
2.6% |
1.9% |
Sternum |
2 |
1 |
2 |
1 |
6 |
4% |
1.3% |
3% |
1.3% |
2.2% |
Face |
- |
- |
3 |
- |
3 |
0.0 |
0.0 |
4.5% |
0.0 |
1.1% |
Inguinal |
3 |
- |
- |
- |
3 |
6% |
0.0 |
0.0 |
0.0 |
1.1% |
Lip |
1 |
- |
- |
- |
1 |
2% |
0.0 |
0.0 |
0.0 |
0.4% |
Lobe |
12 |
- |
- |
- |
12 |
24% |
0.0 |
0.0 |
0.0 |
4.5% |
Breast |
6 |
23 |
10 |
25 |
64 |
12% |
30.3% |
15.2% |
32.5% |
23.8% |
Hand |
- |
1 |
- |
- |
1 |
0.0 |
1.3% |
0.0 |
0.0 |
0.4% |
Shoulder |
2 |
2 |
- |
1 |
5 |
4% |
2.6% |
0.0 |
1.3% |
1.9% |
Ear |
10 |
24 |
20 |
22 |
76 |
20% |
31.6% |
30.3% |
28.6% |
28.3% |
Leg |
- |
1 |
- |
- |
1 |
0.0 |
1.3% |
0.0 |
0.0 |
0.4% |
Neck |
1 |
2 |
3 |
3 |
9 |
2% |
2.6% |
4.5% |
3.9% |
3.3% |
Fist |
- |
- |
1 |
- |
1 |
0.0 |
0.0 |
1.5% |
0.0 |
0.4% |
Chest |
- |
3 |
4 |
3 |
10 |
0.0 |
3.9% |
6.1% |
3.9% |
3.7% |
Total |
50 |
76 |
66 |
77 |
269 |
Table 4 - Frequency distribution of patients according to location and year.
Figure 3 - Kaplan-Meier estimator for total treatment time according to location and whether
or not treatment was completed (p<0.0001).
Figure 3 - Kaplan-Meier estimator for total treatment time according to location and whether
or not treatment was completed (p<0.0001).
Most injuries referred came from male and female plastic surgeons (63%), followed
by Dermatology (12%), Head and Neck Surgery (3%), and Mastology (0.4%). In 20% of
cases, there was no information on the specialty that referred the patient to the
Radiotherapy sector.
Regarding education, 38% completed or attended high school, 29% completed or were
attending higher education, and 15% and 2% completed or attended elementary school
II and I, respectively. In all, 3% of the patients were illiterate and in 11% of the
cases this information was not available (Table 5). According to the Kaplan-Meier estimator (Figure 4), illiterate patients completed less treatment than those with complete elementary
and middle classes (p<0.0001).
Table 5 - Distribution of frequency of patients according to schooling and year.
Education |
Year |
Total |
2015 |
2016 |
2017 |
2018 |
Elementary 1 |
1 |
1 |
3 |
1 |
6 |
2% |
1.3% |
4.6% |
1.3% |
2.2% |
Elementary 2 |
15 |
11 |
8 |
6 |
40 |
30% |
14.5% |
12.1% |
7.8% |
14.9% |
Average |
16 |
34 |
25 |
28 |
103 |
32% |
44.7% |
37.9% |
36.4% |
38.3% |
Illiterate |
1 |
- |
2 |
6 |
9 |
2% |
0.0 |
3% |
7.8% |
3.4% |
N/D |
5 |
1 |
19 |
7 |
32 |
10% |
1.3% |
28.8% |
9.1% |
11.9% |
Higher |
12 |
29 |
9 |
29 |
79 |
24% |
38.2% |
13.6% |
37.7% |
29.4% |
Total |
50 |
76 |
66 |
77 |
269 |
Table 5 - Distribution of frequency of patients according to schooling and year.
Figure 4 - Kaplan-Meier estimator for total treatment time according to schooling and whether
or not treatment was completed (p<0.0001).
Figure 4 - Kaplan-Meier estimator for total treatment time according to schooling and whether
or not treatment was completed (p<0.0001).
There was a predominance of women undergoing this treatment, corresponding to 70%
of the treated lesions. Furthermore, we observed that women tend to complete more
treatment than men (Table 6) in a statistically significant way (p=0.04). This finding is also confirmed when
evaluating the number and volume of larger doses in women, with p-values of 0.03 and
0.02. The average age of women was also higher, being 34 years for women and 24 years
for men. Using the Kaplan-Meier estimator to assess the relationship between sex and
treatment time as factors for completing or not completing radiotherapy sessions,
there was no statistically significant difference (Figure 5).
Table 6 - Frequency distribution of patients according to gender and if treatment was completed.
Completed |
Sex |
Total |
Feminine |
Masculine |
No |
15 |
13 |
28 |
7.9% |
16.2% |
10.4% |
Yes |
174 |
67 |
241 |
92.1% |
83.8% |
89.6% |
Total |
189 |
80 |
269 |
Table 6 - Frequency distribution of patients according to gender and if treatment was completed.
Figure 5 - Kaplan-Meier estimator for total treatment time according to gender and whether or
not treatment was completed (p=0.18).
Figure 5 - Kaplan-Meier estimator for total treatment time according to gender and whether or
not treatment was completed (p=0.18).
Another interesting assessment was that female patients had a higher mean age than
men, with more radiation doses received and, therefore, a greater number of applications,
but in a total treatment time similar to that of men (Table 7).
Table 7 - Mean, and standard deviation refer to age, dose, number of applications, and treatment
time according to gender.
|
Sex |
P |
Masculine |
Feminine |
Age (in years) |
24.9 |
34.2 |
<0.0001 |
10.5 |
10.7 |
Doses |
3417.5 |
3664.0 |
0.03 |
1030.8 |
759.4 |
Number of applications |
17.0 |
18.3 |
0.02 |
5.2 |
3.9 |
Time (in days) |
43.6 |
45.2 |
0.56 |
22.3 |
18.1 |
Table 7 - Mean, and standard deviation refer to age, dose, number of applications, and treatment
time according to gender.
In 43% of the lesions, some previous treatment had already been tried without success;
in 41% of the cases, this was impossible to determine. Using the Kaplan-Meier estimator,
no statistical difference was observed for completing the radiotherapy scheme in those
who had or had not previously undergone other treatments. (Figure 6).
Figure 6 - Kaplan-Meier estimator for total treatment time according to previous treatment and
whether or not treatment was completed (p=0.34).
Figure 6 - Kaplan-Meier estimator for total treatment time according to previous treatment and
whether or not treatment was completed (p=0.34).
According to the Kaplan-Meier estimator (Figure 7), patients referred by the Dermatology and Head and Neck Surgery specialties tended
to complete more treatment than those referred by Plastic Surgery (p=0.002).
Figure 7 - Kaplan-Meier estimator for total treatment time by specialty and whether or not treatment
was completed (p=0.002).
Figure 7 - Kaplan-Meier estimator for total treatment time by specialty and whether or not treatment
was completed (p=0.002).
DISCUSSION
Keloids, being benign alteration, can easily have their treatment neglected for several
reasons. Therefore, we consider it essential that the doctor who conducts this type
of treatment, in addition to knowing the available techniques, also knows how to identify
and guide their patients about the evolution of the treatment and the importance of
completing it, especially because it has high rates of relapse when not done properly.
From the analysis of the medical records, we observed some findings that can guide
our attention during the consultations to achieve better results for the patients.
Some studies demonstrate a higher prevalence and incidence of keloids in the black
population of African origin24; however, in our review, we observed a greater predominance of patients declared
to be white. This may be related to the historical and social fact that in Brazil,
blacks have their health neglected, not seeking health services to treat benign conditions.
It is also necessary to consider the great miscegenation of the Brazilian population,
which means that many declared white patients have African roots. The Botucatu region
is predominantly colonized by Europeans, which may also interfere with these data.
Fortunately, the racial factor was not decisive for the patient to complete or not
the treatment.
The scar’s location suggests that it is related to the formation of keloids since
the areas that suffer the most stretching or elongation have a higher frequency of
pathological scars25. Our study observed their higher prevalence in the ears, breasts, and abdomen. Other
body regions, such as the face and scalp, were less frequent or absent. These data
are similar to the literature26. Furthermore, there was a greater chance of completing the treatment for neck, back
and chest injuries than for abdomen and earlobe injuries. Thus, it was unclear whether
exposed areas influenced prolonged treatment commitment.
We noted that the causes of keloid formation were predominantly from surgical incisions,
with almost half of the cases followed by earrings. Such patients tended to complete
less treatment compared to those with keloid scars secondary to acne or of undetermined
cause, with statistical significance.
Another interesting fact was that illiterate patients completed less treatment than
those with complete primary and secondary education, which indicates an influence
of schooling on adherence to complete treatment.
We observed that the average age of the patients was between 24 and 34 years old,
characterizing a young and economically active population, that is, people who are
inserted in the labor market and will miss many working days of service during treatment,
which has an average of 43 to 45 days. This can have a major negative impact on the
completion of treatment, favoring relapses over time.
Some studies show a predominance of keloids in women, with a possible relationship
with estrogen levels27. There are many reports of worsening symptoms during pregnancy, for example. In our
analysis, women sought the health service more than men, which justifies their great
predominance, more than two-thirds, in the total number of cases; in addition, female
patients tended to complete more treatment than males.
Furthermore, women were older on average than men, receiving higher numbers of radiation
doses performed in more applications; however, the total treatment time was similar,
which may suggest that male patients are attending on dates outside the deadline,
lengthening the time, but without completing it properly. These data align with what
we know about men seeking fewer health services28 and being less adherent to the proposed treatments.
When reviewing the medical literature, we observed that there are many ways described
for treating keloid scars. Due to the great challenge of the definitive and effective
treatment of this pathological scar, new therapeutic modalities and combinations of
previous treatments are constantly emerging.
Radiotherapy reduces the action of fibroblasts on keloids in a dose-dependent manner29. Currently, after its great evolution in the 20th century, it presents itself in
two main forms: internal and external. Brachytherapy is studied as an internal option,
while electron beams and X-rays are the most common external application forms. Although
some studies indicate the superiority of brachytherapy in preventing keloid recurrence30, many meta-analyses have not been able to confirm this in a statistically significant
way13.
By associating surgical excision with early radiotherapy, superior results were found11.
It is important to emphasize that the adverse signs and symptoms of radiotherapy are
similar to those of corticoids, involving erythema, desquamation, and depigmentation;
however, the complaint of pain is not frequent19. In our review, we could not properly identify these complaints due to the descriptions
not clearly reporting whether or not there were such complaints.
As a limitation of this study, it was impossible to assess the current rate of HC-FMB
recurrence with the proposed therapies and clinically reassess the patients who had
their data reviewed in the medical records.
CONCLUSION
Postoperative radiotherapy on keloids is a treatment enshrined in the medical literature
and an important tool for plastic surgeons who manage these pathological scars. Treatment
is usually long-term and should be started early after surgery, requiring patient
commitment to achieve the best results.
There was a predominance of women and white patients seeking and receiving the complete
treatment, while people with low education could not adequately complete the treatment,
and may have lower therapeutic success rates.
Therefore, changing the approach to patients with less education and those who are
male will help improve adherence and short- and long-term outcomes for these patients.
1. Hospital das Clínicas da Faculdade de Medicina de Botucatu, Cirurgia Plástica,
Botucatu, SP, Brazil.
2. Hospital das Clínicas da Faculdade de Medicina de Botucatu, Radioterapia, Botucatu,
SP, Brazil.
Corresponding author: Balduino Ferreira de Menezes-Neto Unesp - Pronto Socorro Rua Doutor Adolfo Pardini Filho, 1028, Chácara Recreio Vista
Alegre, Botucatu, SP, Brazil. CEP: 18608-760E-mail: balduinofmneto@gmail.com